Table 4.
Univariate and multivariate predictors of atrial fibrillation recurrence between 1 week and 30 days after electrical cardioversion
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR [CI 95%] | P | OR [CI 95%] | P | |
| Age, years | 1.07 (0.96–1.19) | 0.24 | ||
| Gender, male=1 | 0.99 (0.19–4.94) | 0.9 | ||
| AF history, years | 1.15 (0.89–1.49) | 0.3 | ||
| AF episode duration before CV, days | 1.003 (0.99–1.02) | 0.6 | ||
| Coronary artery disease | 3.42 (0.38–31.08) | 0.3 | ||
| Diabetes | 1.43 (0.25–8.23) | 0.7 | ||
| Chronic obstructive pulmonary disease | 0.95 (0.09–9.31) | 0.9 | ||
| Chronic kidney disease | 2.28 (0.39–13.05) | 0.4 | ||
| Left ventricular ejection fraction, % | 0.86 (0.72–1.03) | 0.09 | 0.79 (0.54–1.15) | 0.2 |
| Left atrial diameter, mm | 1.06 (0.85–1.32) | 0.6 | ||
| Left atrial emptying fraction <38% | 3.18 (0.62–16.24) | 0.16 | 10.35(0.29–36.24) | 0.2 |
| NPT I, nmol/L | 1.11 (0.96–1.28) | 0.17 | 0.96 (0.65–1.41) | 0.8 |
| NPT II, nmol/L | 1.31 (0.99–1.72) | 0.05 | 1.79 (0.61–5.24) | 0.3 |
| NPT III, nmol/L | 1.26 (0.96–1.65) | 0.09 | 1.32 (0.66–2.61) | 0.4 |
| IL-6 I, pg/mL | 1.09 (0.82–1.45) | 0.5 | ||
| IL-6 II, pg/mL | 0.98 (0.81–1.17) | 0.8 | ||
| IL-6 III, pg/mL | 0.93 (0.62–1.41) | 0.7 | ||
| ACEI/ARB | 2.85 (0.56–14.52) | 0.21 | ||
| Statin | 0.75 (0.08–7.12) | 0.8 | ||
ACEI - angiotensin-converting enzyme inhibitor; AF - atrial fibrillation; ARB - angiotensin II receptor blocker; CI - confidence interval; CV - electrical cardioversion; IL-6 - interleukin-6; NPT - neopterin; OR - odds ratio